抗CCP抗体的历史背景及在类风湿性关节炎的应用
摘要
类风湿关节炎(Rheumatoid a rthritis,RA)因其早期症状复杂多样且不典型,常常给临床诊断带来困难,进而延误治疗导致病情进展。故早期诊断是影响RA预后的决定因素。抗环瓜氨酸肽抗体(抗CCP抗体)是类风湿性关节炎(RA)早期诊断的一种较灵敏的标记物。本文就抗CCP抗体的历史背景以及其在类风湿性关节炎中的应用作一综述。
出处
《内蒙古医学杂志》
2010年第S6期31-34,共4页
Inner Mongolia Medical Journal
参考文献15
-
1吴庆军,曾小峰,唐福林,张奉春,董怡,赵岩,田新平,史艳萍,张乃峥.类风湿关节炎早期诊断的血清学研究和临床应用[J].医学研究杂志,2006,35(5):43-44. 被引量:27
-
2李鸿斌,张奉春.B淋巴细胞克隆清除治疗类风湿关节炎的研究进展[J].中华医学杂志,2005,85(42):3021-3024. 被引量:4
-
3Thomas D?rner,Karl Egerer,Eugen Feist,Gerd R Burmester.Rheumatoid factor revisited[J].Current Opinion in Rheumatology.2004(3)
-
4F. A.van Gaalen,S. P.Linn‐Rasker,W. J.van Venrooij,B. A.de Jong,F. C.Breedveld,C. L.Verweij,R. E. M.Toes,T. W. J.Huizinga.Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study[J].Arthritis & Rheumatism.2004(3)
-
5Erik R.Vossenaar,Albert J.W.Zendman,Walther J.van Venrooij,Ger J.M.Pruijn.PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease[J].Bioessays.2003(11)
-
6Braun-Moscovici Y,Markovits D,Zinder O,et al.Anti-cyclic citrullinated protein antibodies as a predictor of re-sponse to anti-tumor necrosis factor-alpha therapy in pa-tients with rheumatoid arthritis[].The Journal of Rheuma-tology.2006
-
7Arnett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[].Arthritis and Rheumatism.1988
-
8Nienhuis R L F,Mandema E.A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor[].Annals of the Rheumatic Diseases.1964
-
9Simon M,Girbal E,Sebbag M,et al.The cytokeratin filament-aggregating protein, filaggrin is the target of the so-called "antikeratin autoantibodies:, autiantibodies specific for rheumatoid arthritis[].Journal of Clinical Investigation The.1993
-
10Schellekens GA,de Jong BA,van den Hoogen FHJ,et al.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies[].The Journal of Clinical Investigation.1998
二级参考文献29
-
1Edwards JC, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford), 2001,40:205-211.
-
2De Vita S, Zaja F,Sacco S, et al. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis. Arthritis Rheum,2002, 46:2029-2033.
-
3Leandro MJ, Edwards JCW, Cambridge G.Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis,2002,61:883-888.
-
4Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med,2004,17,350:2572-2581.
-
5Hainsworth JD. Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.Arthritis Res Ther, 2003,5:S12-16.
-
6Cambridge G, Leandro MJ, Edwards JC,et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum, 2003,48:2146-2154.
-
7Szczepan′ ski L, Szechin′ ski J, Filipowicz-Sosnowska A,et al.Infusions of rituximab in patients with rheumatoid arthritis are well tolerated. Ann Rheum Dis, 2003, (Suppl 1):171.
-
8Moore J, Ma D, Will R,et al. A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation. Bone Marrow Transplant,2004,34:241-247.
-
9Bridges SL. Update on autoantibodies in rheumatoid arthritis.Curr Rheumatol Rep,2004,6:343-350.
-
10Ng YC, Peters DK, Walport MJ. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation. Arthritis Rheum,1988,31:99-107.
共引文献30
-
1阿斯亚斯地克.针灸按摩疗法对治疗膝关节炎的临床疗效[J].中国卫生产业,2013,10(2). 被引量:3
-
2铁宁.抗环胍氨酸肽抗体的研究进展[J].内蒙古医科大学学报,2013,35(S2):446-450.
-
3顾庆,顾德良,赵陆伍.AKA APF及抗CCP联合检测与类风湿关节炎的早期诊断[J].河北医学,2007,13(5):509-512. 被引量:4
-
4吕诚,徐世杰,肖诚,阎小萍,赵林华,王建明,李梢,吕爱平.类风湿性关节炎RF阳性与阴性患者外周血CD4^+细胞基因表达的差异[J].细胞与分子免疫学杂志,2008,24(2):159-161. 被引量:5
-
5杨云娇,郑文洁,于孟学,张奉春.抗CD20单克隆抗体在风湿性疾病治疗中的应用[J].北京医学,2008,30(2):114-116.
-
6吴庆军,曾小峰,史艳萍,白依娜,甘晓丹,唐福林.抗瓜氨酸化蛋白/肽抗体对类风湿关节炎的诊断价值[J].中华临床免疫和变态反应杂志,2008,2(4):261-265. 被引量:4
-
7吴庆军,曾小峰,史艳萍,白依娜,甘晓丹,唐福林.第1、2代抗环瓜氨酸肽抗体对类风湿关节炎诊断价值的比较[J].中华临床免疫和变态反应杂志,2009,3(2):87-90. 被引量:6
-
8赵琳,任素华,侯爱萍.类风湿因子与抗环瓜氨酸肽抗体对类风湿关节炎诊断价值的分析[J].中国实用医药,2009,4(36):67-67. 被引量:3
-
9曾惠琼,方向红,张小燕,董慧娟,叶志中.老年类风湿关节炎临床特点分析[J].疑难病杂志,2010,9(2):129-130. 被引量:7
-
10曲杰,石宏宴,董枫.抗CCP抗体与RF联合检测的临床诊断意义[J].慢性病学杂志,2010,12(6):508-509. 被引量:4
-
1罗亮,谢灿茂.体外膜肺氧合在危重症患者的应用[J].国际呼吸杂志,2014,34(23):1829-1833. 被引量:1
-
2Douglas G.Altman,Kenneth F.Schulz,David Moher,Matthias Egger,Frank Davidoff,Diana Elbourne,Peter C.Gφtzsche,Thomas Lang,姚巡.报告随机对照试验的CONSORT声明修订版:说明与详述(六)[J].中国循证医学杂志,2006,6(2):139-141. 被引量:7
-
3周亚锋,方剑乔.HLA-DR与类风湿性关节炎相关性研究进展[J].现代中西医结合杂志,2008,17(9):1452-1453. 被引量:6
-
4唐福林.类风湿关节炎干细胞移植的临床研究[J].医学研究通讯,2004,33(2):30-32.
-
5王勇刚.中西医结合治疗类风湿性关节炎的临床观察[J].实用中西医结合临床,2010,10(5):27-28.
-
6铁宁.抗环胍氨酸肽抗体的研究进展[J].内蒙古医科大学学报,2013,35(S2):446-450.
-
7S.R.Benatar,R.Upshur,彭红,王雪静.结核病与贫困:能够(应该)做什么?[J].国际结核病与肺部疾病杂志,2011(1):56-62.
-
8张宏誉.变态反应一百年[J].华中医学杂志,2006,30(4):263-263. 被引量:1
-
9肖萤,张桂英.类风湿关节炎的影像学诊断[J].医学临床研究,2005,22(3):404-406. 被引量:4
-
10糜春霞.循证护理在心血管疾病中的临床应用进展[J].中外医疗,2009,28(30):147-147. 被引量:5